Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Glioblastoma 2Central Nervous System Neoplasms 2Oligodendroglioma 1Gliosarcoma 1Cognition Disorders 1Brain Neoplasms 1Astrocytoma 1

Interventions

Radiotherapy 19Vincristine 12Lomustine 11Temozolomide 9Procarbazine 8Cisplatin 7Carboplatin 7Etoposide 5Cyclophosphamide 5Chemotherapy, Adjuvant 5Granulocyte Colony-Stimulating Factor 4Filgrastim 4Carmustine 4etoposide phosphate 3Thiotepa 2Surgical Procedures, Operative 2Radiosurgery 2Peripheral Blood Stem Cell Transplantation 2Neoadjuvant Therapy 2Methotrexate 2Isotretinoin 2Ifosfamide 2Early Intervention, Educational 2Dihematoporphyrin Ether 2DNA Methylation 2sodium thiosulfate 1Thioguanine 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Central Nervous System Neoplasms × DNA Methylation × Clear all
NCT00626990 2023-09-11

CATNON

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Active not recruiting
751 enrolled 18 charts
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00482677 2023-08-22

Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme

Canadian Cancer Trials Group

Phase 3 Completed
562 enrolled 11 charts
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡